Skip to main content
. 2022 Nov 11;101(45):e31543. doi: 10.1097/MD.0000000000031543

Table 1.

Comparison between the variceal and non-variceal study population.

Parameter Variceal Non-variceal P-value
Age (years/mean ± SD) 59 ± 11.2 65 ± 14.9 <.0001
Gender (n, %)
 Female (n, %) 200 (36.6%) 338 (33.9%) .08
 Male (n, %) 304 (60.4%) 657 (66.1%) .08
 Rebleeding rate (n, %) 18.4% 8.8% <.0001
 Mortality rate (n, %) 8.5% 10.7% .2
 Hemorrhagic shock (n, %) 6.7% 9.8% .05
 Anemia
 Mild (n, %) 201 (40.1%) 227 (22.8%) <.0001
 Moderate (n, %) 136 (26.9%) 442 (44.4%) <.0001
 Severe (n, %) 146 (28.9%) 226 (22.8%) .009
 Total bilirubine (mg/dL, mean ± SD) 3.40 ± 1.86 1.03 ± 0.7 <.0001
 Creatinine (mg/dL, mean ± SD) 1.12 ± 0.78 1.01 ± 0.1 <.0001
 Thrombocytopenia (n, %) 420 (83.4%) 105 (10.5%) <.0001
 ALT (UI/L, mean ± SD) 59.0 ± 9.5 34.1 ± 8.4 <.0001
 AST (UI/L, mean ± SD) 93.3 ± 52.0 40.1 ± 6.5 <.0001
 INR (mean ± SD) 1.41 ± 0.5 1.02 ± 0.01 <.0001
 Natrium (mmmol/L, mean ± SD) 135.8 ± 7.7 138.0 ± 5.2 <.0001
 Potasium (mmol/L, mean ± SD) 3.7 ± 1.2 4.1 ± 0.9 <.0001
 Surgery transfer/embolization (n, %) 2 (0.3%) 29 (2.9%) .0007
Therapy <.0001
 PPI only (n, %) 439 (44.1%)
 Endoscopic therapy (n, %) 502 (99.6%) 556 (55.7%)
 Variceal banding (n, %) 472 (94.1%)
 Variceal sclerosis (n, %) 30 (5.9%)
 Single method(hemostatic clip/thermal coagulation) 296 (29.7%)
 Combined methods (adrenaline injection + clip/coagulation) 260 (26.2%)
Presentation (n, %)
 Melena 203 (40.2%) 500 (50.2%) .0002
 Hematemesis 84 (8.4%) 60 (6.0%) .08
 Melena + hemetemesis 119 (32.0%) 184 (18.6%) <.0001
 Hematochesia 98 (19.4%) 251 (25.2%) .01
 Blood transfusion 144 (28.5%) 220 (22.1%) .006
 Hospitalization days 9.7 ± 1.2 5.0 ± 0.5 <.0001

ALT = alaniane aminotransferase, AST = aspartat aminotransferase; proton pump inhibitor, INR = international normalized ratio, SD = standard deviation.